It is hoped the new treatment, which involves heating only the tumours with a highly focused ultrasound, will mean men can be treated without an overnight stay in hospital and avoiding the distressing side effects associated with current therapies. Read more.
Dr. Rajiv Singal MD, FRCSC Head, Division of Urology, Toronto East General Hospital Lecturer, Department of Surgery, University of Toronto Supervisor, Clinical Endourology and Minimally Invasive Fellowship, Toronto East General Hospital Toronto, Canada Prostate cancer remains a uniquely challenging disease. It is very common and its clinical consequences range from harmless to lethal. The challenge remains to try to distinguish between these two ends of the spectrum. Doing so will allow us to better tailor treatment, to avoid significant side effects when not necessary, and to intervene early when an individual is at risk. CLICK ON THE
5-alpha Reductase Inhibitors Help Prostate Cancer Patients on Active Surveillance Jill Stein Published Online: Monday, May 14, 2012 With reference to Antonio Finelli, MD, University Health Network, Princess Margaret Hospital Click here to view article.
5-alpha Reductase and Active Surveillance Read More »
New Therapies for Prostate Cancer: The Practicalities Jeannette Y. Wick, RPh, MBA Published Online: Tuesday, May 15, 2012 Click here to view article.
February 2007 Dr. Robert Nam speaks on Radical Prostatectomy Dr. Robert Nam and Winston Klass at our Feb. 21/07 Awareness Meeting – Slideshow Read about it in our April 2007 ‘Awareness’ Newsletter. March 2007 Dr. Andrew Loblaw speaks on “Hormone Therapy after Radiation, Brachytherapy: Seed Implants & HDR” Winston Klass and Dr. Andrew Loblaw at our March 21, 2007 Awareness Meeting Dr. Andrew Loblaw addresses ‘Man to Man’ on the topic:”Hormone Therapy after Radiation, Brachytherapy: Seed Implants & HDR” at our March 21, 2007 Awareness Meeting Read about it in our April 2007 ‘Awareness’ Newsletter. May 2007 Dr. Scott Berry
2007 Awareness Nights Read More »
May 2008 Dr. Joseph Chin from London, Ontario Explains Robotic Surgery and HIFU Chairman Aaron Bacher with our May 2008 Awareness Night guest speaker Dr.Joseph Chin, from London Ontario. Read about it our September 2008 ‘Awareness’ Newsletter March 2008 Dr. Roger Buckley (North York General Hospital) Teaches Us “Prostate Cancer 101 – The Journey” Our March 2008 Awareness Night guest speaker Dr. Roger Buckley (North York General Hospital) and Man to Man Awareness Night Coordinator Winston Klass. Read about it in our April 2008 ‘Awareness’ Newsletter.
2008 Awareness Nights Read More »
CLICK ON THE BLUE TEXT BELOW, TO GO TO OUR VIDEOS. Click here for > Part One ” Prostate Health & Nutrition “ Eileen Fauster BA RAP C.Ir CPCC RhA ARHN Holistic Cancer Therapist, Nutritionist, Acupuncturist & Allergist Eileen Fauster talks about actively strengthening your own immunity and adopting a health-promoting lifestyle by incorporating a healing-conducive nutrition plan. Click here for >Part TWO “Herbalist Morwenna Given BA MA (Oxon) BSc m.OHA BHG RH Medical Herbalist Morwenna Given discusses the treatment and control of prostate cancer with evidence-based plant medicine in a holistic context. ——————- CLICK ON THE
The March 2012 Newsletter is available by clicking here. Some of the content: · Dr. Finelli discusses types of surgery · PCCN-Toronto enters team in 2012 Father’s Day Walk/Run · Two dieticians headline our next Scotiabank Awareness Night meeting · TIEd Together Photo Exhibit · New Board of Director and Treasurer added · Meet Bill Sceviour, board member and survivor · PCCN Leader’s Conference heading to Regina · Tino Cotaras retires · Meet Scotiabank’s Janet Slasor · The PEARL opens at the Odette Cancer Centre
March 2012 Newsletter Read More »
Management of Metastatic Castration-resistant Prostate Cancer Abstract The management of men with metastatic castration-resistant prostate cancer (CRPC) has taken several leaps forwards in the last two years, with the demonstration of improved overall survival with three novel agents (sipuleucel-T, cabazitaxel and abiraterone acetate) and a significant delay in skeletal-related events observed with denosumab. … Click here for more.
Management of Metastatic Castration-resistant Prostate Cancer Read More »
Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial Interpretation Dutasteride could provide a beneficial adjunct to active surveillance for men with low-risk prostate cancer. Click here for full article.
Dutasteride in localised prostate cancer management Read More »